34769495|t|Clioquinol Decreases Levels of Phosphorylated, Truncated, and Oligomerized Tau Protein.
34769495|a|The neuropathological hallmarks of Alzheimer's disease (AD) are senile plaques (SPs), which are composed of amyloid beta protein (Abeta), and neurofibrillary tangles (NFTs), which consist of highly phosphorylated tau protein. As bio-metal imbalance may be involved in the formation of NFT and SPs, metal regulation may be a direction for AD treatment. Clioquinol (CQ) is a metal-protein attenuating compound with mild chelating effects for Zn2+ and Cu2+, and CQ can not only detach metals from SPs, but also decrease amyloid aggregation in the brain. Previous studies suggested that Cu2+ induces the hyperphosphorylation of tau. However, the effects of CQ on tau were not fully explored. To examine the effects of CQ on tau metabolism, we used a human neuroblastoma cell line, M1C cells, which express wild-type tau protein (4R0N) via tetracycline-off (TetOff) induction. In a morphological study and ATP assay, up to 10 muM CQ had no effect on cell viability; however, 100 muM CQ had cytotoxic effects. CQ decreased accumulation of Cu+ in the M1C cells (39.4% of the control), and both total and phosphorylated tau protein. It also decreased the activity of c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (p38 MAPK) (37.3% and 60.7% levels of the control, respectively), which are tau kinases. Of note, activation of protein phosphatase 2A (PP2A), which is a tau phosphatase, was also observed after CQ treatment. Fractionation experiments demonstrated a reduction of oligomeric tau in the tris insoluble, sarkosyl soluble fraction by CQ treatment. CQ also decreased caspase-cleaved tau, which accelerated the aggregation of tau protein. CQ activated autophagy and proteasome pathways, which are considered important for the degradation of tau protein. Although further studies are needed to elucidate the mechanisms responsible for the effects of CQ on tau, CQ may shed light on possible AD therapeutics.
34769495	0	10	Clioquinol	Chemical	MESH:D007464
34769495	123	142	Alzheimer's disease	Disease	MESH:D000544
34769495	144	146	AD	Disease	MESH:D000544
34769495	152	166	senile plaques	Disease	MESH:D058225
34769495	168	171	SPs	Disease	MESH:D058225
34769495	218	223	Abeta	Gene	351
34769495	230	253	neurofibrillary tangles	Disease	MESH:D055956
34769495	255	259	NFTs	Disease	MESH:D055956
34769495	321	326	metal	Chemical	MESH:D008670
34769495	386	391	metal	Chemical	MESH:D008670
34769495	426	428	AD	Disease	MESH:D000544
34769495	440	450	Clioquinol	Chemical	MESH:D007464
34769495	452	454	CQ	Chemical	MESH:D007464
34769495	461	466	metal	Chemical	MESH:D008670
34769495	528	532	Zn2+	Chemical	-
34769495	537	541	Cu2+	Chemical	-
34769495	547	549	CQ	Chemical	MESH:D007464
34769495	605	624	amyloid aggregation	Disease	MESH:C000718787
34769495	671	675	Cu2+	Chemical	-
34769495	688	708	hyperphosphorylation	Disease	
34769495	712	715	tau	Gene	4137
34769495	741	743	CQ	Chemical	MESH:D007464
34769495	747	750	tau	Gene	4137
34769495	802	804	CQ	Chemical	MESH:D007464
34769495	808	811	tau	Gene	4137
34769495	834	839	human	Species	9606
34769495	840	853	neuroblastoma	Disease	MESH:D009447
34769495	865	868	M1C	CellLine	CVCL:H720
34769495	913	917	4R0N	CellLine	CVCL:0I88
34769495	923	935	tetracycline	Chemical	MESH:D013752
34769495	989	992	ATP	Chemical	MESH:D000255
34769495	1013	1015	CQ	Chemical	MESH:D007464
34769495	1066	1068	CQ	Chemical	MESH:D007464
34769495	1073	1082	cytotoxic	Disease	MESH:D064420
34769495	1092	1094	CQ	Chemical	MESH:D007464
34769495	1121	1124	Cu+	Chemical	MESH:D003300
34769495	1132	1135	M1C	CellLine	CVCL:H720
34769495	1247	1270	c-Jun N-terminal kinase	Gene	5599
34769495	1272	1275	JNK	Gene	5599
34769495	1281	1317	p38 mitogen-activated protein kinase	Gene	1432
34769495	1319	1327	p38 MAPK	Gene	1432
34769495	1454	1458	PP2A	Gene	5524
34769495	1513	1515	CQ	Chemical	MESH:D007464
34769495	1592	1595	tau	Gene	4137
34769495	1603	1607	tris	Chemical	-
34769495	1619	1627	sarkosyl	Chemical	MESH:C025231
34769495	1648	1650	CQ	Chemical	MESH:D007464
34769495	1662	1664	CQ	Chemical	MESH:D007464
34769495	1696	1699	tau	Gene	4137
34769495	1751	1753	CQ	Chemical	MESH:D007464
34769495	1961	1963	CQ	Chemical	MESH:D007464
34769495	1967	1970	tau	Gene	4137
34769495	1972	1974	CQ	Chemical	MESH:D007464
34769495	2002	2004	AD	Disease	MESH:D000544
34769495	Positive_Correlation	MESH:D007464	5524
34769495	Negative_Correlation	MESH:D007464	4137
34769495	Association	MESH:D008670	MESH:D055956
34769495	Negative_Correlation	MESH:D007464	MESH:C000718787
34769495	Negative_Correlation	MESH:D003300	MESH:D007464
34769495	Negative_Correlation	MESH:C025231	MESH:D007464
34769495	Association	MESH:D058225	351
34769495	Negative_Correlation	MESH:D007464	5599
34769495	Association	MESH:D008670	MESH:D000544
34769495	Positive_Correlation	MESH:D007464	MESH:D064420
34769495	Association	MESH:D008670	MESH:D058225
34769495	Negative_Correlation	MESH:D007464	1432

